SMARCB1 and Coffin-Siris syndrome: This finding aligns with previous reports indicating that individuals with Coffin-Siris syndrome harboring germline mutations in the C-terminal CCD domain of SMARCB1, and specifically R377H (ClinVar Accession: VCV000030203.13), do not develop cancers at higher rates than the population20.